Diligent Pharma Completes $8.27 Million Series A

other

▤ Summary

PRINCETON, NJ, Diligent Pharma announced the closing of an $8.27 Million Series A financing round led by FCA Venture Partners. Diligent Pharma Inc, a private vendor qualification and risk management organization, offering a centralized technology platform for streamlining vendor qualification in clinical trial execution, announced the closing of an $8.27 Million Series A financing round led by FCA Venture Partners. Additional investors include PJC, and GenHenn Capital along with private investors. (c)2011-2020 by Massinvestor, Inc. For contact info, please check out our about page.

▥ Classifications

industries
No industries detected
applications
No applications detected

◇ AskAI Classifications

Labels
No AI classifications detected

▦ Linked Companies